Agenda
The Online Experience Is Open!
- Learn from experts in the field of breast surgery
- A broad array of clinical and practical topics
- All General Session content in an engaging, user-friendly format
- Access innovative scientific and clinical concepts
- Self-paced, in-depth learning
- Earn up to 18 AMA PRA Category 1 Credit(s)™
Coding and Reimbursement Symposium
Moderators: Richard Fine, MD, FACS; Walton Taylor, MD, FACS
-
Welcome and Introduction
Richard Fine, MD, FACS; Walton Taylor, MD, FACS -
2023/2024 Update- What’s New?
Richard Fine, MD, FACS; Walton Taylor, MD, FACS -
Discussion of RUC/CPT Process
Richard Fine, MD, FACS; Walton Taylor, MD, FACS -
Coding Dilemmas and Solutions
Richard Fine, MD, FACS; Walton Taylor, MD, FACS -
Q&A
John Wayne Critical Issues in Breast Cancer Forum 2024: Tailoring and De-escalation in 2024
Moderators: Preya Ananthakrishnan, MD, FACS; Bret Taback, MD, FACS
-
Welcome and Introduction
Preya Ananthakrishnan, MD, FACS; Bret Taback, MD, FACS -
Is MRI Overutilized in Work up of Primary Breast Cancer
Marissa Howard-McNatt, MD, FACS -
Eliminating Breast Surgery After Neoadjuvant Systemic Therapy
Henry Kuerer, MD, PhD, FACS -
RxPonder: Do all Premenopausal Node Positive Require Chemotherapy?
William Sikov, MD -
Radiation Genomics: From Arctic to DCISionRT to Polar
Julia White, MD, FACR, FASTRO -
Q&A
Oncoplastics Forum
Moderators: Patricia Clark, MD, FACS, FSSO; Jessica Ryan, MD, FACS
-
Welcome and Introduction
Patricia Clark, MD, FACS, FSSO; Jessica Ryan, MD, FACS -
How Does Oncoplastic Surgery Impact Radiation Delivery?
Stephanie Valente, DO, FACS -
Optimizing Oncoplastic Surgery
Sadia Khan, DO, FACS, FACOS -
The Implant Imperative: Who, Why, When?
William Scarlett, DO, MHCM, FACS, FACOS -
ASBrS Oncoplastic Certification
Jill Dietz, MD, MHCM, FACS -
Q&A
Cancer Genetics 2024
Moderators: Lisa Curcio, MD, FACS; Kevin Hughes, MD, FACS
-
Welcome and Introduction
Lisa Curcio, MD, FACS; Kevin Hughes, MD, FACS -
Are All Panel Tests Created Equal?
Jennifer Plichta, MD, MS, FACS -
Beyond Surgery: How Genetic Mutations Affect Care
Vivian Bea, MD, MBS, FACS -
Population Testing: Is It Ready for Prime Time
David Euhus, MD, FACS -
Q&A
Presidential Address: Lead with Your Story
-
Presidential Address Introduction
Judy Boughey, MD, FACS -
Presidential Address: Lead with Your Story
Susan Boolbol, MD, FACS
Scientific Oral Presentations I
Moderators: Zahraa Al-Hilli, MD, FACS; Sarah Blair, MD, FACS
-
Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities
Alexa Glencer, MD -
Diagnostic Delay Among Young Women with Breast Cancer
Katherine Fleshner, MD -
Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer with Positive Nodes on Targeted Axillary Dissection
Alexandra Moore, MD -
The Role of Clipping the Lymph Node in Clinically Node Positive Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer: Impact on Axillary Surgery in the ISPY-2 Clinical Trial
Kayla Switalla, BS -
Evolving Economics: The Erosion of Medicare Reimbursement in Breast Surgery (2003-2023)
Terry Gao, MD -
Lymphedema Rates Following Axillary Lymph Node Dissection with and without Immediate Lymphatic Reconstruction: A Prospective Trial
James Jakub, MD -
GEnetic Testing For All breast Cancer patienTS (GET FACTS) – Results of a randomized clinical trial
Anna Weiss, MD, FACS -
Cryoablation Without Excision for Early-Stage Breast Cancer; ICE3 Trial 5 year follow up on Ipsilateral Breast Tumor Recurrence
Richard Fine, MD, FACS
Neoadjuvant Forum
Moderators: Roshni Rao, MD, FACS; Lorraine Tafra, MD, FACS
-
Welcome and Introduction
Roshni Rao, MD, FACS; Lorraine Tafra, MD, FACS -
Advancing Neoadjuvant Endocrine Therapy in Premenopausal Women
J. Michael Dixon, OBE, MD -
Luminal A Breast Cancer: Is There a Neoadjuvant Pathway?
Nathalie Johnson, MD, FACS -
Downstaging the Axilla With Neoadjuvant Therapy
Sarah McLaughlin, MD, FACS -
Neoadjuvant Radiation for Early Staged Cancer
Deborah Farr, MD, FACS -
Q&A
Great Debates
Moderator: Michael Alvarado, MD, FACS
-
Welcome and Introduction
Michael Alvarado, MD, FACS -
Annual MRI is a critical component of High-Risk Screening:(LTR>20%) (YES)
Patrick Borgen, MD, FACS -
Annual MRI is a critical component of High-Risk Screening:(LTR>20%) (NO)
Carla Fisher, MD, MBA, FACS -
Do all ypN1 need Axillary Dissection (YES)
Mahmoud El-Tamer, MD, FACS -
Do all ypN1 need Axillary Dissection? (NO)
Julie Margenthaler, MD, FACS -
Q&A
Quickshot Presentations
Moderators: Preeti Subhedar, MD, FACS; Paul Thiruchelvam, BSc, MD, FACS, PhD
-
Limitations in Utilizing Clinicopathologic Factors Alone in Identifying Patients with DCIS who Benefit from Radiotherapy after Breast-Conserving Surgery
Julie Margenthaler, MD, FACS -
Contemporary Axillary Surgical Management in Patients with Pathologically Node Positive Disease After Neoadjuvant Chemotherapy: A Survey of Members of the American Society of Breast Surgeons
Anna Weiss, MD, FACS -
Surgery Plays a Leading Role Even in Over 90 Breast Cancer Patients Stage
Massimo Ferrucci, MD, PhD -
The Utility of Frozen Section Diagnosis Following Neoadjuvant Chemotherapy in Patients with Clinically Node Negative HER2-positive or Triple Negative Breast Cancer
Kerollos Wanis, MD -
Outcomes of Oncoplastic Reduction Mammoplasty for Patients with Invasive Lobular Carcinoma of the Breast: Positive Margins, Completion Mastectomy Rates, and Recurrence Free Survival
Israel Falade, BS -
Perception of Timely Breast Cancer Diagnosis and Treatment at NAPBC Centers
Danielle Thompson, MD -
Prepectoral Versus Subpectoral Breast Reconstruction After Mastectomy: Long-Term Patient Reported Outcomes and Surgical Outcomes
Anna Stachura, MD -
Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma
Tesia McKenzie, MD -
Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients After Neoadjuvant Chemotherapy
Kush Lohani, MBBS, MS
Social Media and Your Practice
Moderators: Stephanie Serres, MD, PhD; Jennifer Tseng, MD, FACS
-
Welcome and Introduction
Stephanie Serres, MD, PhD; Jennifer Tseng, MD, FACS -
Importance of Branding
Camelia Lawrence, MD, FACS -
Keeping Social Media Safe for Physicians
Beth DuPree, MD, FACS, ABOIM -
Medical Ethics and Social Media
Lillian Erdahl, MD, FACS -
Can Social Media Improve Health Outcomes?
Akiko Chiba, MD, FACS -
Q&A
Keynote Address
-
Keynote Address Introduction
Susan Boolbol, MD, FACS -
Code Blue: Healthcare.
Why Medicine is Flatlining, and How AI can Resuscitate It
David Gruen, MD, MBA, FACR
Hoag Hospital Surgical Innovation Forum: Advancing Breast Cancer Surgical Care 2024
Moderators: Steven Cai, MD, FACS; Sharon Lum, MD, MBA, FACS
-
Welcome and Introduction
Steven Cai, MD, FACS; Sharon Lum, MD, MBA, FACS -
Second Ipsilateral Breast Cancer: Where Are We Now?
Kari Rosenkranz, MD, FACS -
Omitting Axillary Staging in Primary Breast Cancer
Ted James, MD, MHCM, FACS -
Primary Surgery in N1 Disease
David Edmonson, MD, FACS -
Q&A
Best Papers of 2023
Presenter: Helen Pass, MD, FACS
Best Of...
Moderators: Nora Hansen, MD, FACS; Terry Sarantou, MD, MS, FACS, FSSO
-
Welcome and Introduction
Nora Hansen, MD, FACS; Terry Sarantou, MD, MS, FACS, FSSO -
SABCS
E. Shelley Hwang, MD, MPH, FACS -
ASCO
Kelly Hunt, MD, FACS -
ASTRO
Julia White, MD, FACR, FASTRO -
Q&A
Scientific Oral Presentations II
Moderators: Julia Tchou, MD, PhD, FACS; Mediget Teshome, MD, MPH, FACS
-
Presentation and Management of Granulomatous Mastitis in the United States: Results of an American Society of Breast Surgeons Registry Study
Nimmi Kapoor, MD, FACS -
Internal Mammary Lymphadenopathy Does not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results From the I-SPY2 Clinical Trial
Mara Piltin, DO, FACS -
Real World Implications of the SOUND Trial
Andreas Giannakou, MD -
Does the Type of Endocrine Therapy Differentially Affect Quality of Life in Older (≥ 70 years) Women with Early-stage Breast Cancer?
Keva Li -
Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast Conserving Surgery
Elle Clelland, BS -
Surgical outcomes from the phase 3 KEYNOTE-756 study of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab plus endocrine therapy for early-stage high-risk ER+/HER2− breast cancer
Peter Fasching, MD
Health Equity
Moderators: Ronda Henry-Tillman, MD, FACS; Jane Mendez, MD, FACS
-
Welcome and Introduction
Ronda Henry-Tillman, MD, FACS; Jane Mendez, MD, FACS -
Creating Equity Across Ethnicity
Lisa Newman, MD, MPH, FACS, FASCO, FSSO -
Optimizing Fertility Preservation: Where Are We Now?
Kristin Rojas, MD, FACS -
Improving Risk-based Breast Cancer Screening Across Ethnicities
Zahraa Al-Hilli, MD, FACS -
Q&A
Life After Breast Cancer
Moderators: Jay Harness, MD, FACS; Jessica Maxwell, MD, MS, FRCSC, FACS
-
Welcome and Introduction
Jay Harness, MD, FACS; Jessica Maxwell, MD, MS, FRCSC, FACS -
Consequences of Treatment and Sexual Health
Taryn Smith, MD -
Do Lifestyle Interventions Impact Outcome?
Cory Donovan, MD -
Integrative Medicine and Symptom Management
Jay Harness, MD, FACS -
Q&A
"How I Do It" Videos
Moderators: Paul Baron, MD, FACS; Courtney Vito, MD, FACS
-
Clough Inframammary Mastopexy
Michele Carpenter, MD, FACS -
The Use of Oncoplastic Breast Surgery in the Treatment of Male Breast Cancer
Nicketti Handy, MD -
IntraOperative Ultrasound Guided Breast Conserving Surgery (IOUS) Associated with Medial InterCostal Artery Perforator (MICAP) Flap Mammoplasty
Massimo Ferrucci, MD, PhD -
10 Commandments for A Grisotti Flap
Anshumi Desai, MD -
Excision of Nipple Epidermal Inclusion Cyst During Lactation
Katrina Mitchell, MD, FACS
Enough About You. What About Me?
Moderators: Eric Manahan, MD, MBA, FACS; Helen Pass, MD, FACS
-
Welcome and Introduction
Eric Manahan, MD, MBA, FACS; Helen Pass, MD, FACS -
Beyond RVU's: A Surgeons Value
Shawna Willey, MD, FACS -
Ergonomics for a Lifetime in the OR
Katherine Kopkash, MD, FACS -
APP's and My Practice
Katharine Yao, MD, FACS -
Panel Discussion
Katherine Kopkash, MD, FACS; Eric Manahan, MD, MBA, FACS; Helen Pass, MD, FACS; Shawna Willey, MD, FACS; Katharine Yao, MD, FACS
The Uncommon Common
Moderators: Jamie Patterson, MD; Kay Yoon-Flannery, DO, MPH, FACS
-
Welcome and Introduction
Jamie Patterson, MD; Kay Yoon-Flannery, DO, MPH, FACS -
Inflammatory Breast Cancer: 2024 Update
Kandace McGuire, MD, FACS -
Lymphoma to Angiosarcoma: The Rare Tumors
Theresa Schwartz, MD, MS, FACS -
Cryoablation: Is It Ready for Primetime?
Michael Berry, MD -
Transgender Breast Health: What You Need to Know Now
Chandler Cortina, MD, MS, FSSO, FACS -
Q&A
Benign Breast Disease
Moderators: Kristalyn Gallagher, DO, FACOS, FACS; Manpreet Kohli, MD, FACS
-
Welcome and Introduction
Kristalyn Gallagher, DO, FACOS, FACS; Manpreet Kohli, MD, FACS -
Evolving Management of IGM
Sarah Blair, MD, FACS -
From Unusual Inflammatory Disorders
Carinne Anderson, MD, FACS -
Are All High-Risk Lesions Created Equal?
Ekaterini Tsiapali, MD, FACS -
Choosing the Risk Tool That Works
Katherina Calvillo, MD, FACS -
Q&A